They, the people
By Patricia J. Williams,
TLS
| 08. 06. 2021
In 1853, Joseph-Arthur, Comte de Gobineau published a tract entitled “Essay on the Inequality of the Human Races”, in which he argued that “history springs only from contact with the white races” and that miscegenation with “commoners” as well as with “yellow” and “black” races leads to the “demise of civilization”. Widely credited with popularizing the concept of the Aryan master race, Gobineau’s thoughts found purchase among pro-slavery Americans and, eventually, became an ideological cornerstone for the American Breeder’s Association, the American Eugenics Society and the Nazi party. His royalist assertions of elite white “bloodlines” have been enduringly influential in the United States.
Few have had a greater hand in carrying Gobineau’s notions into the present than Charles Murray. Along with J. Philippe Rushton, Arthur Jensen, Richard Herrnstein and Nicholas Wade, Murray has championed social Darwinism, an ideology that divides humans into biologically distinct “races” with distinct genetic propensities that neatly predict everything from penis size to brain function and criminal disposition. Their bottom line is that dark-skinned people are evolutionarily limited and thus unsuited to modern life.
Hard scientific...
Related Articles
Since the “CRISPR babies” scandal in 2018, no additional genetically modified babies are known to have been born. Now several techno-enthusiastic billionaires are setting up privately funded companies to genetically edit human embryos, with the explicit intention of creating genetically modified children.
Heritable genome editing remains prohibited by policies in the overwhelming majority of countries that have any relevant policy, and by a binding European treaty. Support for keeping it legally off limits is widespread, including among scientists...
By Angus Liu, Fierce Pharma | 06.16.2025
A second patient has died following treatment with Sarepta Therapeutics’ Elevidys, raising more doubts about the Duchenne muscular dystrophy (DMD) gene therapy’s safety profile.
Sarepta and its ex-U.S. partner Roche reported the death early Sunday. Like the first case, disclosed...
By Sophie Alexander and Ike Swetlitz, Bloomberg | 06.25.2025
A California-startup focused on genetically editing human embryos — a step toward creating so-called designer babies — is raising money as many of Silicon Valley’s ultra-rich turn their attention to one of the most controversial technologies in medicine.
Bootstrap Bio...